<TABLE>
UNITED STATES SECURITIES AND EXCHANGE COMMISSION OMB APPROVAL
FORM 3 WASHINGTON, D.C. 20549 OMB Number: 3235-0104
Expires: September 30, 1998
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Estimated average burden
hours per response......0.5
Filed pursuant to Section 16(a) of the Securities Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
Print or Type Responses)
<S> <C> <C> <C>
- -----------------------------------------------------------------------------------------------------------------------------------
1. Name and Address of 2. Date of Event Re- 4. Issuer Name and Ticker or Trading Symbol
Reporting Person quiring Statement Schein Pharmaceutical, Inc. (SHP)
(Month/DayYear)
- -------------------------------
(Last) (First) (Middle) 5. Relationship of Reporting Person(s) 6. If Amendment, Date of Original
August 21, 1998 to Issuer (Month/Day/ Year)
Rosenthal Harvey (Check all applicable)
- -------------------------------
3. IRS or Social Se- /X/ Director / / 10% Owner 7. Individual or Joint/Group
curity Number of / / Officer (give / / Other (specify Filing (check Applicable Line)
60 State Street/ Suite 700 Reporting Person title below) below) /X/ Form filed by One
- ------------------------------- (Voluntary) Reporting Person
Street ---------------------- / / Form filed by More than
One Reporting Person
Boston MA 02109
- -----------------------------------------------------------------------------------------------------------------------------------
(City) (State) (Zip)
</TABLE>
<TABLE>
Table I -- Non-Derivative Securities Beneficially Owned
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
1. Title of Security 2. Amount of Securities 3. Ownership 4. Nature of Indirect Beneficial Ownership
(Instr. 4) Beneficially Owned From: Direct (Instr. 5)
(Instr. 4) (D) or Indirect
(I) (Instr. 5)
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Over)
* If the form is filed by more than one reporting person, SEE Instruction 5(b)(v). SEC 1473(7-96)
</TABLE>
<PAGE>
<TABLE>
FORM 3 (continued) Table II -- Derivative Securities Beneficially Owned (e.g., puts, calls, warrants,
options, convertible securities)
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
1. Title of Derivative 2. Date Exer- 3. Title and Amount of Securities 4. Conver- 5. Owner- 6. Name of Indirect
Security cisable and Underlying Derivative Security sion or ship Beneficial Ownership
(Instr. 4) Expiration Date (Instr. 4) Exercise Form of (Instr. 5)
(Month/Day/Year) Price of Deriv-
------------------------------------------------------- Deriv- ative
Amount ative Security:
Date Expira- or Security Direct
Exer- tion Title Number (D) or
cisable Date of Indirect
Shares (I)
(Instr. 5)
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses:
/s/ Harvey Rosenthal September 18, 1998
-------------------- ------------------
**Intentional misstatements or omissions of facts constitute Federal Criminal **Signature of Date
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Reporting Person
Note: File three copies of this Form, one of which must be manually signed. If
space provided is insufficient, see Instruction 6 for procedure.
</TABLE>
